NCT03846895View on ClinicalTrials.gov

Vaginal CO2 Laser in Postmenopausal Women With Overactive Bladder Syndrome (OAB)

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

May 12, 2018

Primary Completion Date

September 15, 2021

Study Completion Date

February 15, 2022

Conditions
Overactive Bladder (OAB)
Interventions
DEVICE

Microablative Fractional CO2 laser

3 therapies intravaginally administered will be applied at monthly intervals

Trial Locations (1)

11528

Urogynecological Unit of Alexandra Hospital, Athens

All Listed Sponsors
lead

National and Kapodistrian University of Athens

OTHER

NCT03846895 - Vaginal CO2 Laser in Postmenopausal Women With Overactive Bladder Syndrome (OAB) | Biotech Hunter | Biotech Hunter